These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 690322)

  • 1. The effects of insulin glucose administration in fulminant hepatic failure.
    Burn J; Williams WD
    Intensive Care Med; 1978 Jul; 4(3):133-6. PubMed ID: 690322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the management of fulminant hepatic failure.
    Scharschmidt BF
    Med Clin North Am; 1975 Jul; 59(4):927-35. PubMed ID: 1079899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of glucagon and insulin in therapy of fulminant hepatic failure.
    Okita K; Matsuda S; Hata K; Morimoto T; Sasaki M; Fukumoto Y; Kodama T; Takemoto T
    Gastroenterol Jpn; 1979 Oct; 14(5):453-7. PubMed ID: 520769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and glucose to reduce catabolic response to injury in burned patients.
    Hinton P; Allison SP; Littlejohn S; Lloyd J
    Lancet; 1971 Apr; 1(7703):767-9. PubMed ID: 4101272
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormalities of sodium excretion and other disorders of renal function in fulminant hepatic failure.
    Wilkinson SP; Arroyo VA; Moodie H; Blendis LM; Williams R
    Gut; 1976 Jul; 17(7):501-5. PubMed ID: 964682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral edema during hepatic encephalopathy in fulminant hepatic failure.
    Watanabe A; Shiota T; Tsuji T
    J Med; 1992; 23(1):29-38. PubMed ID: 1573340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of adult respiratory distress syndrome after recovery from fulminant hepatic failure.
    Khanlou H; Souto H; Lippmann M; Muñoz S; Rothstein K; Ozden Z
    Am J Med Sci; 1999 Feb; 317(2):134-6. PubMed ID: 10037117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of fulminant hepatic failure with insulin and glucagon. A randomized, controlled trial.
    Woolf GM; Redeker AG
    Dig Dis Sci; 1991 Jan; 36(1):92-6. PubMed ID: 1702048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of antithrombin III supplementation in fulminant hepatic failure.
    Langley PG; Hughes RD; Forbes A; Keays R; Williams R
    J Hepatol; 1993 Mar; 17(3):326-31. PubMed ID: 8315261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current therapeutic possibilities in hepatic encephalopathy].
    Imler M
    Minerva Med; 1977 Mar; 68(15):961-76. PubMed ID: 854217
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin, glucose, and potassium in the treatment of congestive heart failure.
    Allison SP; Morley CJ; Burns-Cox CJ
    Br Med J; 1972 Sep; 3(5828):675-8. PubMed ID: 4650847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.
    Ring-Larsen H; Palazzo U
    Gut; 1981 Jul; 22(7):585-91. PubMed ID: 7262632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery despite impaired cerebral perfusion in fulminant hepatic failure.
    Davies MH; Mutimer D; Lowes J; Elias E; Neuberger J
    Lancet; 1994 May; 343(8909):1329-30. PubMed ID: 7910328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches in the management of fulminant hepatic failure.
    Krone CL
    Ariz Med; 1971 Apr; 28(4):284-7. PubMed ID: 4930377
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary transfer of patients with fulminant hepatic failure.
    Dryden CM; Simon EJ
    Br J Hosp Med; 1995 Feb 1-14; 53(3):70-3. PubMed ID: 7728319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant hepatic failure treated with anti-endotoxin antibody.
    Manthous CA; Schmidt GA; Kemp R; Wood LD
    Crit Care Med; 1992 Nov; 20(11):1617-9. PubMed ID: 1424707
    [No Abstract]   [Full Text] [Related]  

  • 17. Fulminant hepatic failure treated with anti-endotoxin antibody.
    Tompkins RG
    Crit Care Med; 1992 Nov; 20(11):1507. PubMed ID: 1424690
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis of renal failure in cirrhosis and fulminant hepatic failure.
    Wilkinson SP; Portmann B; Hurst D; Williams R
    Postgrad Med J; 1975 Aug; 51(598):503-5. PubMed ID: 1234330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis.
    Vilstrup H; Gluud C; Hardt F; Kristensen M; Køhler O; Melgaard B; Dejgaard A; Hansen BA; Krintel JJ; Schütten HJ
    J Hepatol; 1990 May; 10(3):291-6. PubMed ID: 2195106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 in patients with fulminant hepatic failure: influence of high-volume plasmapheresis.
    Therkelsen K; Hansen B; Larsen F
    Transplant Proc; 1995 Dec; 27(6):3508-9. PubMed ID: 8540073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.